KUALA LUMPUR: In another milestone for Malaysia, a new affordable Hepatitis C combination treatment of which clinical trials have been held in the country, has shown not only a high 97% cure rate but also better efficacy of treating the most severe form of Hepatitis.
The treatment, which uses the new drug candidate ravidasvir (in combination with a generic version of sofosbuvir) has been shown to be safe and effective, with extremely high cure rates for patients, according to interim results from the Phase II/III STORM-C-1 trial.
Subscribe to The Star Yearly Premium Plan for 30% off
Cancel anytime. Ad-free. Full access to Web and App.
Monthly Plan
RM 13.90/month
RM 9.73/month
Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.
Annual Plan
RM 12.39/month
RM 8.63/month
Billed as RM 103.60 for the 1st year, RM 148 thereafter.
